AUTO CAR T cell therapy
AUTO-LT1
Phase 2 mab active
Quick answer
AUTO CAR T cell therapy for Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy is a Phase 2 program (mab) at Autolus Therapeutics plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Autolus Therapeutics plc
- Indication
- Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy
- Phase
- Phase 2
- Modality
- mab
- Status
- active